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ABSTRACT
Objective To assess the predictive value of observed-to-expected lung-to-head ratio (O/E LHR) for survival and
chronic lung disease (CLD) in survivors of left-sided congenital diaphragmatic hernia (CDH) in an era of standardized
neonatal treatment, and to evaluate the predictive value of the O/E LHR trajectory for survival.
Methods This retrospective cohort study was performed in two high-volume CDH centers in the Netherlands in
prenatally detected, isolated left-sided CDH patients born between 2008 and 2014. O/E LHR and liver position were
determined using 2D-ultrasonography at three time points during gestation from 19 weeks onwards. Ultrasound
measurements were performed on stored ultrasound data by one single experienced operator blinded to postnatal
outcome.
Results Of the 122 included cases, 77.9% survived of whom 38.9% developed CLD. A signiﬁcant association was found
between the ﬁrst measured O/E LHR and survival and development of CLD in survivors. Prenatal liver position did not
have additional predictive value. No signiﬁcant association was found between the trajectory of the O/E LHR and
survival.
Conclusion In an era of standardized neonatal treatment for neonates with CDH, the ﬁrst measured O/E LHR per
patient signiﬁcantly predicts survival and development of CLD in survivors in isolated left-sided CDH infants. © 2017
The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.
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INTRODUCTION
Congenital diaphragmatic hernia (CDH) occurs in
approximately 1 in 2200 live births.1 Although the survival rate
has signiﬁcantly increased to about 70–80%,2,3 CDH is still a
life-threatening congenital anomaly.4 Various parameters are
related to a worse prognosis like a right-sided CDH,
intrathoracic liver herniation, and associated congenital
and/or chromosomal malformations.5–7
Metkus et al. were the ﬁrst (1996) who described the
predictive value of lung-to-head ratio (LHR) in fetuses with
CDH.8 Because the LHR increases exponentially with gestation
in healthy fetuses,9 the observed-to-expected LHR (O/E LHR)
was introduced in 2007 by Jani et al. after a multicenter study
in 354 isolated CDH fetuses.10 Thereafter, several studies have
demonstrated that the O/E LHR is a useful predictor of
postnatal outcome.11–14
In fetuses with left-sided severe CDH (O/E LHR < 25%) and
fetuses with moderate CDH (O/E LHR 25–34.9% or O/E LHR
35–44.9% with intrathoracic liver herniation), the beneﬁt of
fetoscopic endotracheal occlusion (FETO) is currently being
investigated in randomized controlled studies (NCT01240057
and NCT00763737). Groups are based on survival rates
according to Deprest et al.15 and Jani et al.,10 which is the
largest study to date.10 However, in that period, there was still
a lack of postnatal standardization of treatment, which has
proven to inﬂuence postnatal outcome, reaching survival rates
up to over 80%.3 Secondly, in their study, each of the
participating centers provided the data. Information
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concerning inter-observer reproducibility was not available
and variability in prenatal ultrasound measurements may have
inﬂuenced the results. Thirdly, up to date, there has not been a
longitudinal evaluation of the O/E LHR per individual patient
during pregnancy.
From 2008 onwards, all patients born in participating
centers of the CDH EURO Consortium have been treated
according to a standardized neonatal treatment protocol
which was published in 2010 and recently actualized.16,17
Subsequent high survival rates might inﬂuence validity of the
‘original’ cut-offs and their value for prenatal counseling.
Therefore, we evaluated the predictive value of the prenatally
measured O/E LHR on postnatal survival and development of
chronic lung disease (CLD), when neonates receive standar-
dized treatment in the two Dutch CDH designated centers with
extracorporeal membrane oxygenation (ECMO) availability.
Moreover, we performed longitudinal analyses of the O/E
LHR measurements per patient during gestation.
METHODS
All patients with a prenatal diagnosis of CDH, born between
January 2008 and December 2014, and treated in the Erasmus
University Medical Centre, Rotterdam, The Netherlands or
the Radboud University Medical Centre, Nijmegen, The
Netherlands were included in this observational retrospective
cohort study. Because all infants from the Netherlands with a
CDH are referred to one of the two CDH centers, this
represents a nationwide cohort. Both centers are high-volume
centers (deﬁned as >10 CDH patients per year).18 Exclusion
criteria were deﬁned as: right-sided CDH, termination of
pregnancy, premature birth <30 weeks gestational age (GA),
FETO, and associated major structural or chromosomal
anomalies. Because subjects are not being submitted to any
handling, nor are there rules of human behavior being
imposed, Institutional Review Board approval was waived by
the ethical committee of the Erasmus Medical Center,
Rotterdam, The Netherlands (MEC-2015-517).
The original ultrasound image of a transverse plane of the
fetal chest at the level of the four-chamber view of the heart
was retrieved from patient records and used for measurement
of the contralateral (right) lung. The lung area was measured
by manual tracing of the limits of the lung (mm2), if possible
in multiple images per examination and preferably in an
image recorded for measurement of lung area. Liver position
(intrathoracic or intra-abdominal) was determined by visual
assessment in a transversal plane, as well as a coronal or
sagittal plane if available. The head circumference (mm) was
retrieved from medical records. The O/E LHR was then
calculated as described by Jani et al.19 Ultrasound
measurements were performed on stored images reloaded
on a GE Voluson E8 or E10 system (GE Medical Systems, Zipf,
Austria) at the Department of Obstetrics and Gynecology,
Division of Obstetrics and Prenatal Medicine at the Erasmus
University Medical Centre. The original images where
obtained using the GE Voluson 730/E8 system (GE Medical
Systems, Zipf, Austria). All measurements were performed by
one single operator (N. C. J. Peters) with 5 years of experience
measuring the O/E LHR,20 who was unaware of postnatal
outcome. If there was no image available meeting the
requirements as described by Jani et al.21 a measurement
was regarded as missing. Ultrasound measurements were
performed in the second and third trimester of pregnancy
and were categorized as follows; ultrasound 1: 19+0–24+0 weeks’
gestational age (GA), ultrasound 2: 24+1–29+6 weeks’ GA, and
ultrasound 3: ≥30+0 weeks’ GA. Postnatal patient
characteristics were retrieved from medical records. Patient
demographics included: gestational age at birth, birth weight,
gender, associated major structural or chromosomal
anomalies, side of diaphragmatic hernia, liver position
(intrathoracic/ intra-abdominal) at surgical repair, diaphragmatic
defect size (A/B/C/D, with ‘A’ being the smallest and ‘D’ being the
largest defects),2 need for ECMO, survival, and presence of CLD in
survivors. Survival was deﬁned as survival after the ﬁrst year of
life. CLD was deﬁned as oxygen dependency (>0.21) at day 28
of life.22 Since 2008, all patients have been treated according
to a standardized neonatal treatment protocol, which was
published in 2010 and recently updated in 2016.16,17 ECMO
therapy was available for patients born after >34 weeks of
gestation, with a birth weight above 2000 grams during the
complete study period, without a change in indications for
ECMO during this period. Severity of CDH was divided
according to the same groups as proposed by Deprest et al.15:
extreme CDH (O/E LHR <15%), severe CDH (O/E LHR
15–25%), moderate CDH (O/E LHR 26–35% or O/E LHR
36–45% with intrathoracic liver position), and mild CDH (O/E
LHR 36–45% and liver down or O/E LHR ≥46%).
Statistical analysis
Patient characteristics were described as numbers (%) for
categorical data, or median (interquartile range; IQR) for
continuous data because they were not normally distributed.
The ﬁrst measured O/E LHR per patient was selected and used
for all analyses, except for the longitudinal analyses for which
all measurements per individual patient were evaluated. O/E
LHR was compared between survivors and non-survivors,
and survivors with and without development of CLD, and
comparison between centers using Mann–Whitney tests.
Associations between O/E LHR and mortality, and CLD in
survivors were evaluated using univariable logistic regression
modeling. Multivariable logistic regression analyses with
prenatal liver position and O/E LHR as independent variables
were then used to evaluate their combined predictive value
on survival and development of CLD in survivors. The
calibration of the multivariable logistic regression models was
assessed using the Hosmer–Lemeshow goodness-of-ﬁt test.
The association between O/E LHR and postnatal defect size
was evaluated using the Jonckheere–Terpstra test, whereas
the association between prenatal liver position and postnatal
defect size was evaluated using a linear-by-linear association
chi-square test. Multivariable ordinal logistic regression
analysis was used to determine the association between
postnatal defect size (dependent variable) and the O/E LHR
and prenatal position of the liver (independent variables). An
univariable logistic regression analysis was performed to assess
the association between the gestational age at diagnosis and
survival. Receiver operating characteristic (ROC) curves were
K. G. Snoek et al.
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used to evaluate the prognostic value of O/E LHR for survival
and development of CLD in survivors. Data were presented
as areas under the ROC curves (AUC); [95% CI]. Optimal cut-
off values were determined by maximizing the Youden index
(sensitivity plus speciﬁcity minus 1). Missing observations of
O/E LHR could conceivably be missing not at random,23 if the
more severe cases of CDH are more likely to be detected early
on during pregnancy. To test this hypothesis, univariable
logistic regression analysis was repeated in a selection of
patients in whom the CDH was detected before 24 weeks GA.
Results from this group were compared with the results of
the complete study group to assess whether the O/E LHR
observations are missing at random.23 Then, for the evaluation
of the predictive value of the trajectory of O/E LHR over time
on survival, missing data of O/E LHR 19+0–24+0 weeks GA
(n = 64 patients), O/E LHR between 24+1–29+6 weeks GA
(n = 70), and O/E LHR >30+0 weeks GA (n = 11 patients), were
imputed using multiple imputation by chained equations in
SPSS with 100 imputations. Using the multiple imputation data
set, a linear regression of the O/E LHR at the three time points
was performed for each patient separately, with GA (coded as a
continuous variable) as the only independent variable. The
purpose of this analysis was to summarize the longitudinal
data of O/E LHR using an estimated level (intercept in the
linear regression) and time trend (slope in the linear
regression). The resulting estimates of the intercept and slope
in the linear regressions were used as independent variables
in logistic regressions for survival and CLD in survivors. The
linear regressions were performed using MICROSOFT EXCEL
2010, and all other analyses were performed using SPSS version
21.0 for Windows. A two-sided p-value of<0.05 was considered
statistically signiﬁcant.
RESULTS
During the study period, 238 CDH patients were born alive
with a CDH in one of the two CDH centers in the
Netherlands. In 176 (74%) patients, the CDH was prenatally
detected. Reasons for exclusion from the study are
summarized in Figure 1. In total, 122 patients with a prenatal
diagnosis of an isolated left CDH were included. In the study
group, 95 (77.9%) patients survived, and 37 (38.9%) of the
survivors developed CLD (Table 1). Thirty-eight (31%)
neonates received ECMO treatment, of which 21 died (55%).
For 73 (60%) patients, more than one measurement was
available, so 73 patients with a total of 190 measurements
were available for the longitudinal analyses. The ﬁrst
measured O/E LHR and survival rate of patients with CDH
were not signiﬁcantly different between the two centers with
survival rates of 78.2% at the Erasmus University Medical
Center and 77.1% at the Radboud University Medical Center
(p = 0.90).
In non-survivors and survivors, the median O/E LHR was
35.9% (IQR 29.2–43.0) and 45.7% (IQR 40.5–55.9), respectively
(p < 0.001). The median of the O/E LHR was 44.0% (IQR
36.0–48.8) in survivors with CLD and 48.8% (IQR 41.8–57.7) in
survivors without CLD (p = 0.03). Figure 2 shows the
relationship between the O/E LHR and gestational age for each
patient, stratiﬁed by survival status. There was no signiﬁcant
association between survival and GA at diagnosis (p = 0.30)
nor between the ﬁrst measured O/E LHR and the GA at
diagnosis (p = 0.05).
The relationship between O/E LHR and survival, stratiﬁed by
prenatal liver position in each group is shown in Figure 3. None
of our patients belonged to the extreme CDH group (O/E
LHR < 15%). Only one of four patients (25%) with severe
Figure 1 Flowchart of inclusion. CDH, congenital diaphragmatic hernia; FETO, fetoscopic endotracheal occlusion; GA, gestational age
O/E LHR in congenital diaphragmatic hernia: a multicenter study
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CDH (O/E LHR ≤ 25%) survived. In the moderate group (O/E
LHR 26–35% or O/E LHR 36–45% with intrathoracic liver
position) 29/43 patients (67.4%) survived. In the mild group
(O/E LHR 36–45% and liver down or O/E LHR ≥ 46%), 65/75
patients (86.7%) survived. Fetuses with an O/E LHR of
36–45% with liver up show no statistically signiﬁcant difference
in survival rate in comparison with fetuses with an O/E LHR of
36–45% and liver down, respectively 82% and 76% (p = 0.63). In
Figure 3, 42 instead of 43 patients are in the moderate group
and 73 instead of 75 patients in the mild group. Those
differences are explained by the fact that in the moderate
group for one patient prenatal liver position was unknown,
and in the mild group for two patients, the prenatal liver
position was unknown.
Univariable logistic regression analysis showed that a lower
O/E LHR was signiﬁcantly associated with mortality and with
the development of CLD in survivors (Table 2). Multivariable
logistic regression analysis with correction for prenatal liver
position resulted in the same conclusions and showed that
liver position was not of additional value for prediction of
outcome (Table 2). P-values of the Hosmer–Lemeshow test
were larger than 0.05, indicating an adequate model
calibration. Based on ROC analysis, mortality was predicted
correctly by the O/E LHR with an optimal cut-off value of
40.2% (sensitivity 0.76 and speciﬁcity 0.70, AUC 0.77; [0.666–
0.866], p < 0.01) (Figure 4a). Development of CLD in survivors
was predicted by the O/E LHR (AUC 0.64; [0.522–0.751],
p = 0.03) with an optimal cut-off value of 49.9% (sensitivity
0.48 and speciﬁcity 0.81) (Figure 4b).
In a separate univariable analysis in patients with a known
postnatal defect size (n = 104), a statistically signiﬁcant positive
association was found between the O/E LHR and postnatal
defect size (p = 0.02) as well as between the presence of CLD
in survivors and postnatal defect size (p = 0.002). No
statistically signiﬁcant association was found between liver
position and postnatal defect size (p = 0.25). The multivariable
ordinal regression analyses showed that the addition of
Table 1 Background characteristics of CDH patients
Variables CDH patients (n = 122)
Gestational age at delivery (weeks) 38+2 (37+5–38+5)
Birth 30–34 weeks of GA 5 (4.1%)
Birth 34–37 weeks of GA 18 (14.8%)
Birth weight (grams) 3000 (2700–3200)




Unknown/ missing 3 (2.5%)
Postnatal liver position (during surgery)
Intra-abdominal 65 (53.3%)
Intrathoracic 50 (41.0%)
No repair 5 (4.1%)






No repair 5 (4.0%)
Unknown/ missing 13 (10.7%)
ECMO 38 (31.1%)
Survival after ﬁrst year of life 95 (77.9%)
CLD (in survivors) 37 (38.9%)
GA, gestational age; ECMO, extracorporeal membrane oxygenation; CLD, chronic
lung disease; CDH, congenital diaphragmatic hernia.
Data are presented as numbers (%) or median (interquartile range). Defect size was
classiﬁed according to Lally et al.2 with ‘A’ being defects entirely surrounded by
muscle, ‘B’ defects having a small (<50%) and ‘C’ defects having a large (>50%)
portion of the chest wall devoid of diaphragm tissue, and ‘D’ patients having complete
or near complete absence of the diaphragm.
Figure 2 Relationship between the ﬁrst measured observed to expected lung to head ratio (O/E LHR) and gestational age. This ﬁgure shows
the O/E LHR measured at the ﬁrst ultrasound examination per patient. The closed circles represent the neonates that died, and the open circles
represent the survivors. The solid and dashed lines are linear regression lines for the neonates that died and the survivors, respectively
K. G. Snoek et al.
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prenatal liver position was not relevant in the association
between O/E LHR and postnatal defect size (p = 0.41).
The category of CDH severity based on O/E LHR
measurements and prenatal liver position per patient
remained stable for 58 patients (79.5%) of the 73 patients with
at least two ultrasound measurements during the second and
third trimester of pregnancy. In the univariable logistic
regression analysis, no differences were found in predictive
value of the O/E LHR on survival between the selected group
of patients in whom the CDH was detected before 24 weeks
of gestational age and the total patient population. Therefore,
multiple imputation was performed. Longitudinal analyses of
the trajectory of O/E LHR measurements during gestation
showed no signiﬁcant association with survival (p = 0.18).
DISCUSSION
In this nationwide study performed in an era of standardized
neonatal treatment, we demonstrated that the ﬁrst prenatally
measured O/E LHR per patient can predict survival in isolated
left-sided CDH infants. Survival within the different O/E LHR
categories was comparable with data from Jani et al., the
largest multicenter study concerning the predictive value of
the O/E LHR,10 when no international consensus in
standardization of postnatal therapeutic modalities had been
reached and/or had been made available. A lower O/E LHR
was signiﬁcantly associated with development of CLD in
survivors. The O/E LHR remained stable over time during
gestation.
The rationale for the use of O/E LHR is that it provides an
indirect assessment of contralateral lung volume, and
therefore the likelihood of pulmonary hypoplasia.25 Adequate
prenatal counseling, considering the indication for prenatal
treatment (FETO) and expected postnatal prognosis, requires
accurate prediction tools. Jani et al. retrospectively evaluated
the predictive value of O/E LHR in a multicenter study of 354
isolated CDH patients (of whom 329 left-sided), who were
treated without a standardized protocol in a large number of
centers with both high-volume and low-volume case load on
a yearly base.18 A difference between the two studies is, next
to different patient numbers and the presence of standardized
treatment, a different inclusion period (2008–2014 in the
present study vs 1996–2005 in the study by Jani et al.). The
Figure 3 Survival rate according to the fetal observed to expected lung to head ratio (O/E LHR) and fetal liver position in fetuses with isolated
left-sided diaphragmatic hernia. The ﬁlled bars represent fetuses with intrathoracic herniation of the liver and the open bars represent those
without herniation. The numbers inside the bars represent the absolute numbers of survived patients/total number of patients within that
speciﬁc group. The areas between the dashed lines represent the division according to Deprest et al. into groups of estimated severity of
pulmonary hypoplasia based on the O/E LHR in combination with liver position.24 The difference in patient numbers between this ﬁgure and
the total group is explained by the fact that in the moderate group for one patient prenatal liver position was unknown and in the mild group
for two patients the prenatal liver position was unknown
Table 2 Logistic regression analyses for the O/E LHR with outcomes survival and chronic lung disease in survivors
Variable
Univariable analyses Multivariable analyses
OR 95% CI p-value OR 95% CI p-value
Survival Survival
O/E LHR (%) 1.11 1.052–1.168 <0.001 1.11 1.048–1.172 <0.001
Liver position 2.26 0.944–5.425 0.07 0.83 0.310–2.213 0.71
CLD in survivors CLD in survivors
O/E LHR (%) 0.96 0.919–0.997 0.04 0.94 0.902–0.988 0.01
Liver position 1.23 0.520–2.925 0.63 0.55 0.214–1.414 0.21
O/E LHR, observed-to-expected lung-to-head ratio; OR, odds ratio; CI, conﬁdence interval; CLD, chronic lung disease.
For the multivariable analyses prenatal liver position (intrathoracic vs intra-abdominal) was added into the model.
O/E LHR in congenital diaphragmatic hernia: a multicenter study
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presented survival rates in the different categories (severe,
moderate and mild) of O/E LHR in our study are comparable
with the previous studies. Because inclusion criteria in the
Tracheal Occlusion To Accelerate Lung (growth) trial (moderate
CDH (NCT01240057) and severe CDH (NCT00763737)) are
based on these previous studies, it is important that we can
conclude that those criteria are still valid following a nationwide
evaluation in The Netherlands in an era of standardized
neonatal treatment protocol. Improving neonatal therapy is,
however, a moving target explaining that may contribute to
the different overall survival rates between the two study
periods (76% in the present study vs 65% in the study by Jani
et al.). Our data also show that fetuses with an O/E LHR of
36–45% have a survival chance equal to fetus in the mild group
irrespective of liver position. Position of the liver seems more
relevant in fetus with an O/E LHR between 26 and 35%. In the
multivariable logistic regression analysis, however, prenatal
liver position was not signiﬁcantly associated with survival,
postnatal defect size nor with development of CLD in survivors
after adjustment forO/E LHR. In our study, we assessed the liver
position as being a dichotomous variable (intrathoracic or not
intrathoracic). Previous studies have shown, however, that
quantiﬁcation of the extent of liver tissue herniation by
ultrasound orMRI and/or position of the stomach in the thorax
are more predictive for survival, even independent of the O/E
LHR.26–30 The primary aim of our study was to investigate the
validity of the currently used O/E LHR for survival in an era of
standardized neonatal treatment and quantiﬁcation of
herniated liver tissue was not part of the study design.
We found an AUC for survival of 0.77, which is comparable
with previous studies (AUC 0.76 in the study by Jani et al.,10
AUC 0.78 in the study by Ruano et al.,31 and AUC 0.84 in the
study by Kehl et al.32). The relevance for clinical practice of
the cut-off values based on the Youden index is debatable,
because the weight of a possible false positive or false negative
prediction has not been taken into consideration Before
assigning differential weights to the predictions, evaluation of
parents preferences should, however, be further investigated.
In our study, we found a difference in the signiﬁcance of the
association between survival and GA at diagnosis (p0.30) and
the association between the ﬁrst measured O/E LHR and GA
at diagnosis (p0.05). This indicates that a higher absolute
difference in percentage O/E LHR at a later time during
gestation does not immediately result in an overall higher
survival. Deprest et al.15 proposed a division of patients into
categories (extreme/severe/moderate/mild). Because our data
show that 80% of the patients remain in the same O/E LHR
category during the second and third trimester of pregnancy,
those categories rather than absolute percentages seem more
suitable for prenatal counseling.
We found that a lower O/E LHR was signiﬁcantly associated
with development of CLD in survivors. The only studies that
have also evaluated the prognostic value of the O/E LHR for
the development of CLD10,14 found the same result. In
addition, we have shown that a lower O/E LHR is associated
with a larger postnatal defect size as classiﬁed by the Boston
scale and these larger defects are associated with the
development of CLD in survivors. Therefore, it is likely that
prenatally assessed size of the contralateral lung is not only a
predictor of mortality, but also for pulmonary morbidity.
The strengths of this study are the inclusion of a large cohort
of isolated left CDH patients in a relatively short inclusion
period who were all treated according to the same standardized
treatment protocol including the same ECMO protocols, in
Figure 4 (a) Receiver operating characteristic (ROC) curve for
survival. ROC curve for the prediction of survival in neonates with
isolated left-sided congenital diaphragmatic hernia according to cut-
off values of observed-to-expected lung area to head circumference
ratio (continuous line). The dashed line is the reference line. Area-
under the curve: 0.77. (b) ROC curve for development of chronic lung
disease in survivors. ROC curves for the prediction of chronic lung
disease in surviving neonates with isolated left-sided congenital
diaphragmatic hernia according to cut-off values of observed-to-
expected lung area to head circumference ratio (continuous line). The
dashed line is the reference line. Area under the curve: 0.64
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addition to standardized prenatal measurements. Because one
single experienced operator performed all measurements on
storedultrasounddata, inter-observer variability couldnot have
inﬂuenced our results. Cruz-Martinez et al. showed that there is
a learning curve for performing O/E LHRmeasurements, which
emphasizes the importance of an experienced operator.20 We
used the tracing method to calculate the O/E LHR which was
shown to be superior to the anteroposterior diameter method
in predicting postpartum survival in isolated left-sided
CDH.21,32
A limitation of this study may be that, although O/E LHR was
measured by one observer, measurements were performed on
stored ultrasound images, which may not have been the
perfect section of the cross-sectional view of the fetal thorax
at the level of the four-chamber view of the heart. However, if
an image did not meet the criteria for measurement of the lung
area as described by Jani et al.,21 a measurement was regarded
as missing.
CONCLUSIONS
In isolated left-sided CDH patients, O/E LHR predicts survival
and development of CLD in survivors in an era of a standardized
neonatal treatment protocol, and the previously established
categories of severe, moderate and mild CDH remain valid.
Prenatal liver position (‘liver up’ vs ‘liver down’) was not
signiﬁcantly associated with survival nor with development of
CLD in survivors after adjustment for O/E LHR.
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WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• The O/E LHR ratio is currently used for prenatal prediction of
postnatal outcome in fetuses with CDH.
WHAT DOES THIS STUDY ADD?
• An evaluation of the predictive value of the O/E LHR ratio for survival
and development of chronic lung disease in fetuses with CDH in an
era of standardized neonatal treatment.
• Insight into the predictive value of the O/E LHR trajectory throughout
gestation.
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